Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

NCT01611935 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01611935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01611935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2013
Completion date
September 6, 2016
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic shock